Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home. India, United States, Drugs (Pharmaceuticals), Supply Chain, Factories and Manufacturing, International Trade and World Market, Generic Brands and Products Read More
America Wants to Make More Generic Drugs. India Shows Why That’s Hard.
